id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-Z-0025-0016,FDA,FDA-2021-Z-0025,Securing Updated and Necessary Statutory Evaluations Timely; Proposal To Withdraw or Repeal,Proposed Rule,Withdrawal,2021-10-29T04:00:00Z,2021,10,2021-10-29T04:00:00Z,2021-12-29T04:59:59Z,2021-12-29T02:00:16Z,2021-23472,0,0,0900006484dff4c7
FDA-2021-Z-0025-0015,FDA,FDA-2021-Z-0025,Medical Devices; Class I Surgeon’s and Patient Examination Gloves,Notice,Determinations,2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T14:11:35Z,2021-15891,0,0,0900006484c0e025
FDA-2021-Z-0025-0014,FDA,FDA-2021-Z-0025,Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation; Withdrawal,Notice,Withdrawal,2021-07-09T04:00:00Z,2021,7,2021-07-09T04:00:00Z,,2021-07-09T19:28:03Z,2021-14637,0,0,0900006484bdf3c6
FDA-2021-Z-0025-0008,FDA,FDA-2021-Z-0025,Withdrawal of Notice Regarding the Food and Drug Administration Drug Review Timeline Transparency; Revocation of Statement of Policy,Notice,Withdrawal,2021-05-03T04:00:00Z,2021,5,2021-05-03T04:00:00Z,,2021-05-03T14:09:03Z,2021-09134,0,0,0900006484ac7a40
FDA-2021-Z-0025-0003,FDA,FDA-2021-Z-0025,"Making Permanent Regulatory Flexibilities Provided During the COVID–19 Public Health Emergency by 
Exempting Certain Medical Devices From Premarket Notification Requirements; Withdrawal of Proposed Exemptions",Notice,Withdrawal,2021-04-16T04:00:00Z,2021,4,2021-04-16T04:00:00Z,,2021-04-16T13:11:51Z,2021-07760,0,0,0900006484aa9678
FDA-2021-Z-0025-0004,FDA,FDA-2021-Z-0025,Medical Devices; Class I Surgeon’s and Patient Examination Glove,Notice,Request for Comments,2021-04-16T04:00:00Z,2021,4,2021-04-16T04:00:00Z,2021-05-18T03:59:59Z,2021-05-18T01:00:47Z,2021-07759,0,0,0900006484aa97fd
FDA-2021-Z-0025-0002,FDA,FDA-2021-Z-0025,Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation,Notice,Proposed Guidelines,2021-01-21T05:00:00Z,2021,1,2021-01-21T05:00:00Z,,2021-01-21T18:32:40Z,2021-01125,0,0,09000064849faabc
FDA-2021-Z-0025-0001,FDA,FDA-2021-Z-0025,Securing Updated and Necessary Statutory Evaluations Timely,Rule,Final Rule,2021-01-19T05:00:00Z,2021,1,2021-01-19T05:00:00Z,,2021-01-21T17:14:56Z,2021-00597,0,0,09000064849f7f15